Delivery Order SPE2DR25D2005-SPE2DR26FE9D4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,608.02 for Promethegan 25 mg suppositories (12-count units) with an ultimate completion date of July 7, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,400.08 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) on December 17, 2025, with completion scheduled for December 18, 2025. This is a firm fixed price, non-set-aside competitive award to be fulfilled at the vendor's Conshohocken, Pennsylvania facility. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of...
- The Defense Logistics Agency awarded a $3,900.48 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) on September 24, 2025, with completion targeted for September 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,031.58 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count) on August 21, 2025, with completion expected by August 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,004.03 firm fixed-price delivery order is for the supply of PROMETHEGAN 25 MG SUPPOSITORY 12S medical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,679.75, is for the delivery of PROMETHEGAN 25 MG SUPPOSITORY 12S, a pharmaceutical product. The contract has a completion date of December 4, 2023, and is a firm fixed-price type with no set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $392.75 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 25 mg suppositories of Promethagan. As the prime contractor, Amerisourcebergen will deliver 12 units of the specified medication to a location in Conshohocken, Pennsylvania by September 7, 2023 to fulfill requirements under the contract. The single award was issued utilizing Amerisourcebergen's Prime Vendor Next contract vehicle, through which it provides pharmaceuticals and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,510.02, is for the supply of 4567844138 PROMETHEGAN 25 MG SUPPOSITORY 12S. This order is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,154.94, is a Firm Fixed Price Delivery Order for the pharmaceutical product "PROMETHEGAN 12.5 MG SUPPOS 12S". The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,492.65 to AmerisourceBergen Drug Corp for the supply of Prometrium 200 mg capsules (30-count units). This competitively awarded, firm fixed-price delivery order, issued on July 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside provisions, with performance...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE9D4Delivery Order
The Defense Logistics Agency awarded a $2,767.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Promethegan 12.5 mg suppositories (12-count) on December 18, 2025, with an ultimate completion date of December 19, 2025. This non-set-aside competitive award was performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Department of Defense healthcare systems, including the Defense Health Agency and other government medical supply chains. The company's extensive federal contract portfolio demonstrates consistent capability to fulfill competitive pharmaceutical procurement requirements across multiple therapeutic domains, from routine medications to specialized medical supplies. This delivery order for Promethegan suppositories supports the DLA's operational medical supply needs within the broader pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 12/17/25 |